Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

7 treatments under study, led by Measurement Of Methadone In The Interstitial Fluid Isf Before And After Prescribed Dose Taken Ex Vivo

Research Leaders

5 sponsors active, led by Cari Health Inc.

Related Conditions

Often studied with 14 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 5 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

1Total
Not Applicable (1)

Trial Status

Completed2
Not Yet Recruiting1
Unknown1
Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 2 completed trials

Clinical Trials (5)

Research Network

Common Treatments

  • Measurement Of Methadone In The Interstitial Fluid Isf Before And After Prescribed Dose Taken Ex Vivo2
  • Isf Extraction Device 22
  • Measurement Of Methadone In The Interstitial Fluid Before And After Prescribed Dose Taken In Vivo2
  • Tacrolimus1
  • Cyp3a4 And Cyp3a5 Genotyping1

Active Sponsors

  • Cari Health Inc.2
  • Medical University of Warsaw1
  • Institut National de la Santé Et de la Recherche Médicale, France1
  • National Science Centre, Poland1
  • University of Alabama at Birmingham1

Top Investigators

Related Conditions

  • Drug Metabolism Poor Cyp2d6related2
  • Methadone Overdose2
  • Methadone Toxicity2
  • Pain Chronic2
  • Liver Transplant Complications1

Activity Timeline